PATENT CLAIM ANALYSIS

Application Number: 15910788
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "181100"]

Abstract:
The present disclosure provides antibody drug conjugates that bind human cMET, their methods of making, and their uses to treat patients having cancer.

Claim (Index 139):
The method of  claim 138 , in which the anti-cMet antibody comprises a VH chain of SEQ ID NO: 78; a VL chain of SEQ ID NO: 79.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15363786', '15363715', '15819153', '14928738', '15747620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582962149599789
- 35 USC 102 Novelty (BERT): 0.5419375536418097
- Combined Prediction Score: 0.736660348828162
- Mean Citation Score: 322.025672
- Max Citation Score: 361.72943
- Similarity Product: 241.693747356593

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test